Aliski William
Insider CIK 1598426 · AGTC Director · XFOR Director · RARE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals, Inc | A Award | 2024-06-10 | 2024-06-11 | 45,000 | — | $0 | 96,667 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2023-06-13 | 2023-06-14 | 45,000 | — | $0 | 51,667 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 14,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 25,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 10,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | D To issuer deriv | 2022-11-30 | 2022-12-01 | 12,000 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | U Tender | 2022-11-30 | 2022-12-01 | 8,500 | — | $0 | 0 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2022-06-06 | 2022-06-27 | 6,667 | — | $0 | 6,667 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2021-11-30 | 2021-12-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2021-06-24 | 2021-06-28 | 4,125 | — | $0 | 4,125 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-06-24 | 2021-06-28 | 2,145 | — | $0 | 66,849 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2021-06-02 | 2021-06-02 | 6,000 | $9.50 | $57.0K | 6,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | G Gift | 2021-02-23 | 2021-02-23 | 1,000 | — | $0 | 64,704 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2021-02-19 | 2021-02-23 | 7,500 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2021-02-19 | 2021-02-23 | 7,500 | $97.85 | $733.9K | 73,204 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-02-19 | 2021-02-23 | 7,500 | $149.01 | $1.12M | 65,704 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2020-12-16 | 2020-12-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-08-21 | 2020-08-25 | 5,000 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-08-21 | 2020-08-25 | 5,000 | $86.57 | $432.8K | 57,018 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-08-21 | 2020-08-25 | 5,000 | $58.74 | $293.7K | 62,018 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2020-06-26 | 2020-06-30 | 4,250 | — | $0 | 4,250 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-06-26 | 2020-06-30 | 2,550 | — | $0 | 57,018 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2020-06-10 | 2020-06-11 | 3,427 | — | $0 | 3,427 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-05-18 | 2020-05-20 | 7,500 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-05-18 | 2020-05-20 | 7,500 | $40.37 | $302.8K | 55,424 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-05-18 | 2020-05-20 | 7,500 | $74.65 | $559.9K | 47,924 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-05-18 | 2020-06-03 | 20,000 | $74.02 | $1.48M | 70,350 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2019-12-04 | 2019-12-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-09-18 | 2019-09-20 | 6,854 | — | $0 | 6,854 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-06-11 | 2019-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-06-11 | 2019-06-13 | 3,000 | — | $0 | 47,924 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | P Buy | 2018-12-14 | 2018-12-18 | 1,200 | $3.24 | $3.9K | 3,700 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | P Buy | 2018-12-14 | 2018-12-18 | 500 | $3.24 | $1.6K | 8,500 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | P Buy | 2018-12-14 | 2018-12-18 | 4,300 | $3.25 | $14.0K | 8,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-12-07 | 2018-12-07 | 6,000 | $49.69 | $298.1K | 90,350 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2018-11-15 | 2018-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-11-08 | 2018-11-08 | 6,000 | $55.67 | $334.0K | 96,350 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-10-08 | 2018-10-09 | 6,000 | $73.38 | $440.3K | 102,350 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | A Award deriv | 2018-09-20 | 2018-09-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-08-08 | 2018-08-08 | 3,750 | $76.66 | $287.5K | 72,610 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2018-06-19 | 2018-06-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-06-19 | 2018-06-20 | 3,000 | — | $0 | 76,360 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-04-19 | 2018-10-09 | 650 | $53.97 | $35.1K | 108,350 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2018-01-23 | 2018-01-25 | 11,500 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2018-01-23 | 2018-01-25 | 11,500 | $21.00 | $241.5K | 73,360 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2017-06-22 | 2017-06-22 | 3,750 | — | $0 | 3,750 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2017-06-22 | 2017-06-22 | 1,875 | — | $0 | 61,860 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2016-12-05 | 2016-12-05 | 6,000 | — | $0 | 11,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2016-12-05 | 2016-12-05 | 6,000 | $21.00 | $126.0K | 65,985 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-12-05 | 2016-12-05 | 4,000 | $77.94 | $311.8K | 61,985 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-12-05 | 2016-12-05 | 2,000 | $78.70 | $157.4K | 59,985 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2016-06-09 | 2016-06-14 | 3,750 | — | $0 | 3,750 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2016-06-09 | 2016-06-14 | 1,875 | — | $0 | 59,985 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-07-27 | 2018-10-09 | 400 | $122.58 | $49.0K | 109,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2015-06-18 | 2015-06-22 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-05-27 | 2018-10-09 | 2,000 | $85.94 | $171.9K | 109,400 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-05-12 | 2018-10-09 | 10,500 | $68.65 | $720.8K | 111,400 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-12-04 | 2014-12-08 | 3,109 | $42.46 | $132.0K | 60,010 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-12-04 | 2014-12-08 | 2,891 | $41.83 | $120.9K | 63,119 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2014-10-20 | 2014-10-22 | 29,108 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2014-10-20 | 2014-10-22 | 29,108 | $3.01 | $87.6K | 66,010 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2014-07-10 | 2014-07-17 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | C Conversion deriv | 2014-02-05 | 2018-10-09 | 266,343 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | C Conversion | 2014-02-05 | 2018-10-09 | 84,970 | — | $0 | 121,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-02-07 | 29,108 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-02-07 | 91,241 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2014-01-30 | 2014-02-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | P Buy | 2014-01-30 | 2014-02-03 | 5,000 | $21.00 | $105.0K | 36,903 | SEC↗ |